40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
40.53%
Revenue growth above 1.5x MTDR's 21.61%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
68.72%
Gross profit growth above 1.5x MTDR's 34.15%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
6650.00%
EBIT growth above 1.5x MTDR's 54.53%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6650.00%
Operating income growth above 1.5x MTDR's 54.53%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-177.89%
Negative net income growth while MTDR stands at 154.90%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-178.67%
Negative EPS growth while MTDR is at 133.33%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-178.67%
Negative diluted EPS growth while MTDR is at 133.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.04%
Share reduction while MTDR is at 7.30%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.04%
Dividend growth of 0.04% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
3.36%
Positive OCF growth while MTDR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-20.69%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-83.97%
Negative 10Y revenue/share CAGR while MTDR stands at 885.81%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-42.93%
Negative 5Y CAGR while MTDR stands at 51.84%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-59.10%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-86.82%
Negative 10Y OCF/share CAGR while MTDR stands at 390.84%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-61.04%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
7.72%
Positive 3Y OCF/share CAGR while MTDR is negative. John Neff might see a big short-term edge in operational efficiency.
-116.27%
Negative 10Y net income/share CAGR while MTDR is at 1550.29%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-116.68%
Negative 5Y net income/share CAGR while MTDR is 192.86%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-188.12%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-75.09%
Negative equity/share CAGR over 10 years while MTDR stands at 54.64%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-3.82%
Negative 5Y equity/share growth while MTDR is at 56.58%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-47.07%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-92.82%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.79%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-78.67%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-41.02%
Firm’s AR is declining while MTDR shows 29.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.68%
Asset growth well under 50% of MTDR's 16.08%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-3.36%
We have a declining book value while MTDR shows 18.05%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.84%
Debt growth far above MTDR's 0.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
10.18%
SG&A growth well above MTDR's 1.17%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.